Work with thought leaders and academic experts from City College of New York

Dr. Andrea Corti holds a PhD in Biomedical Engineering from The City College of New York. His research interests include tissue mechanics, cellular transport, and biomechanics. He received his BS and MS in biomedical engineering with a specialization in Prosthesis and Implant Design from the Politecnico di Milano and the University of Groningen, respectively. He has experience working in both industry and academia, and has been a teaching assistant for several courses in his department.

Biomedical Engineering Ph.D. with extensive research experience in neuroimaging including five publications. Experience teaching and tutoring. Knowledge in algorithm development, testing, and data analysis. Acquiring skills in data science and applied methods of machine learning

**Lawrence A. Klein** received a Bachelor of Electrical Engineering degree from the City College of New York in 1963, an M.S. in Electrical Engineering from the University of Rochester in 1966, and a Ph.D. in Electrical Engineering from New York University in 1973. Dr. Klein is a member of the National Cooperative Highway Research Program (NCHRP) 03-145 Panel to develop guidance for the National Traffic Sensor System Evaluation Program and the 08-157 Panel to determine Best Practices for Data Fusion of Probe and Point Detector Data. He is a past member of the Transportation Research Board’s Highway Traffic Monitoring and Freeway Operations Committees. He led ASTM’s E17 Group V-ITS in developing worldwide standards to specify, install, and evaluate traffic flow sensors. At the French Institute of Science and Technology in Transportation, Planning, and Networks (IFSTTAR) in Bron, France, Dr. Klein lectured at EPFL-LAVOC (Swiss Laboratory of Traffic Facilities at Lausanne Federal Institute of Technology) in Lausanne, Switzerland, and at the EU-sponsored Real-Time Road Traffic Monitoring and Control Summer Workshop. He was also a Visiting Professor at the Harbin Institute of Technology, School of Transportation Engineering and Science, Harbin, China for several years. At Waveband Corporation he served as Director of Advanced Technology Programs. While at Hughes Aircraft Company, he was Principal Investigator on the FHWA Detection Technology for IVHS (later ITS) Program. As Chief Scientist at Aerojet ElectroSystems (TAMS Division), he was responsible for programs that integrated active and passive millimeter-wave and infrared multispectral sensors in satellites and smart "fire-and-forget" weapons. At Honeywell, he developed passive millimeter-wave midcourse missile guidance systems and millimeter-wave sensors to trigger land mines. His books include *Traffic Flow Sensors:* *Technologies, Operating Principles, and Archetypes* (2020), *Sensor and Data Fusion for Intelligent Transportation Systems* (2019), *ITS Sensors and Architectures for Traffic Management and Connected Vehicles* (2018), *Sensor and Data Fusion: A Tool for Information Assessment and Decision Making* (2004, 2012), *Traffic Detector Handbook, 3rd Ed.* (2006), *Sensor Technologies and Data Requirements for ITS* (2001), and *Millimeter-Wave and Infrared Multi-sensor Design and Signal Processing* (1997).

Dr. John Bilello has over 25 years of experience in the pharmaceutical industry, the biotechnology sector, and academic and government laboratories. He was an Associate Professor at the University of Maryland School of Medicine and Albany Medical College. Dr. Bilello joined GlaxoSmithKline (GSK), where he was the Director of Technology Development in Translational Medicine and Genetics. John assessed external technologies in his technology development role, identifying new investment opportunities for GSK’s Technology Investment Board. His work with GSK’s Human Biomarker Laboratories led to tools for stratifying patients and monitoring efficacy in clinical studies. Specifically, he developed biomarkers for enabling studies of new therapeutics for COPD, diabetes/metabolic syndrome, migraine, and neurodegenerative diseases. Before joining GSK, he was a biochemist at Roche Pharmaceuticals, a Volkswagen Fellow at the University of Hamburg (Germany), and the Director of Preclinical Research and Development at two successful biotechnology companies (SRA Lifesciences and Virco Laboratories). As an enthusiastic entrepreneur, John was a founder and Chief Scientific Officer of Ridge Diagnostics, which developed and commercialized a diagnostic for major depressive disorder. At Ridge, he was an inventor on multiple US and international patents and processes. John has authored over seventy publications in refereed journals and more than ten book chapters. An internationally recognized scientist, he was a member of the editorial board for *Antimicrobial Agents and Chemotherapy* (1995-2009). In addition to an established track record of innovative basic and clinical research, Dr. Bilello has extensive experience in project and organizational management. John was a co-founder and Managing Partner of Innovalyst LLC,  a small business accelerator focused on catalyzing product innovation in the Life Sciences.